[28-18-am] Drug Design 2

10:56 AM - 11:08 AM JST(1:56 AM - 2:08 AM UTC)

[28-18-am12S] Development of octaarginine-linked CDP-ribitol derivative for substrate supplementation therapy

○Kyosuke Ohira¹, Atsuhiko Taniguchi^1,2, Rina Kobayashi¹, Kei Mukaiyama¹, Yui Furuya¹, Kazuki Oka¹, Sho Konno^1,2, Akihiro Taguchi^1,2, Hiroshi Manya³, Tamao Endo³, Motoi Kanagawa⁴, Yoshio Hayashi^2,5 (1. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 2. Grad. Sch. Pharm., Tokyo Univ. Pharm. Life Sci., 3. Tokyo Metro. Inst. Gerontol., 4. Grad. Sch.Med., Ehime Univ., 5. Sch. Life Sci., Tokyo Univ. Pharm. Life Sci.)